Nature Reviews Immunology (2018) https://doi.org/10.1038/s41577-018-0061-z Published online 12 September 2018
In Box 1 in the originally published version of this article, three key references referring to mouse and human killer inhibitory receptors were mistakenly deleted during revision of the article. These references have now been added to the corrected version of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiossone, L., Dumas, PY., Vienne, M. et al. Author Correction: Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol 18, 726 (2018). https://doi.org/10.1038/s41577-018-0077-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-018-0077-4
This article is cited by
-
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Journal for ImmunoTherapy of Cancer (2019)
